-
Vioxx: Merck Has No Plans for a Global Settlement Says General Counsel Frazier
Merck Will Continue to Fight Each Vioxx Lawsuit, Including Humeston Case in NJ Merck & Co.’s General Counsel Kenneth Frazier reiterated in the first part of September 2005 that Merck has no interest in…
-
Propulsid: Blockbuster Drug With Danger Signals That Were Ignored
FDA’s Failure to Act in 1998 Foreshadowed Its Later Mishandling of Vioxx and Bextra A June 2005 article in The New York Times ("NYT") by Gardiner Harris and Eric Koli provided insight about how…
-
FDA Mandates “iPLEDGE” Accutane Registry in Effort to Prevent Birth Defects
Patients Must Register by December 31, 2005 to Get Accutane Re-fills In mid-August 2005 the FDA mandated that all patients who uses the acne drug Accutane will have to enroll in a national Accutane…
-
Serzone MDL Class Action Settlement Approved by Federal Court Judge Godwin
More Than 2500 Potential Claimants, However, "Opt-out" of This Serzone Settlement United States District Court Judge Joseph R. Godwin, on September 2, 2005, gave final court approval to a $70 million settlement of Serzone…
-
Eli Lilly Sues Its Insurers to Partially Fund $1 Billion Zyprexa Settlement
$500 Million Sought From Five Insurance Companies for Payment of Zyprexa Claims In a September 2, 2005 article by Jeff Swiatek, of The Indianapolis Star, it was reported that Eli Lilly and Co. filed…
-
Anti-Cancer Drug Herceptin Associated With Significant Risk of Cardiotoxicity
Genentech Says Its Breast Cancer Drug Can Increase Risk of Heart Problems The FDA and Genentech, Inc. have warned healthcare professionals by means of an August 2005 "Dear Doctor" letter of study data linking…
